• Home
  • Services
    • Clinical development
    • Regulatory Consulting
    • Biopharmaceutics & ADME
    • Study feasibility Support
    • CRO, Oversight & Audits
    • GMP Compliance & Audit
    • CSR Reviews
  • More
    • Home
    • Services
      • Clinical development
      • Regulatory Consulting
      • Biopharmaceutics & ADME
      • Study feasibility Support
      • CRO, Oversight & Audits
      • GMP Compliance & Audit
      • CSR Reviews
Get in Touch

  • Home
  • Services
    • Clinical development
    • Regulatory Consulting
    • Biopharmaceutics & ADME
    • Study feasibility Support
    • CRO, Oversight & Audits
    • GMP Compliance & Audit
    • CSR Reviews
Get in Touch

Clinical Development Consulting (Human & Veterinary)

 Our Clinical Development Consulting services provide end-to-end strategic and operational support across the entire product lifecycle for both human and veterinary pharmaceuticals. We partner with innovators, generics manufacturers, and animal health companies to design, execute, and optimize clinical programs that are regulatory-compliant, cost-effective, and scientifically robust. 

Clinical Development Strategy

Protocol Design & Review (Phase I–IV / Pilot & Pivotal)

Protocol Design & Review (Phase I–IV / Pilot & Pivotal)

We help define a comprehensive clinical development roadmap aligned with your target product profile, regulatory pathway, and market objectives. Our strategic guidance ensures efficient progression from early development through post-marketing studies while minimizing risk and timelines. 

Protocol Design & Review (Phase I–IV / Pilot & Pivotal)

Protocol Design & Review (Phase I–IV / Pilot & Pivotal)

Protocol Design & Review (Phase I–IV / Pilot & Pivotal)

Our experts support the design, review, and optimization of clinical study protocols across all phases Phase I–IV clinical trials,Pilot and pivotal studies Human and veterinary indications 

We ensure protocols are scientifically sound, operationally feasible, and regulator-ready, with clear endpoints and risk mitigation strategies.

Bioequivalence (BE) & Bioavailability (BA) Study Planning

Protocol Design & Review (Phase I–IV / Pilot & Pivotal)

  • Study design and statistical considerations
  • Comparator selection 
  • Regulatory expectations for generics and veterinary products

Our approach ensures successful study outcomes and smooth regulatory submissions.

Study Feasibility & Site Selection Support

We conduct thorough feasibility assessments to identify optimal regions, sites, and investigators. Our site selection support focuses on: Patient/subject availability Investigator, experience Infrastructure and compliance readiness

This helps reduce delays and improve study execution.

CRO Selection, Oversight & Audits

GCP Compliance & Inspection Readiness

We assist sponsors in selecting the right CRO partners and provide ongoing oversight to ensure quality delivery. Our services include: CRO evaluation and selection support,Vendor management and governance,Routine audits and performance reviews

This ensures accountability, transparency, and adherence to timelines and budgets.

GCP Compliance & Inspection Readiness

GCP Compliance & Inspection Readiness

We support Good Clinical Practice (GCP) compliance throughout the study lifecycle. Our inspection readiness services include Gap assessments,Mock inspections,SOP reviews and compliance training
We help you stay prepared for regulatory inspections and audits at all times.

Copyright © 2026 NEXPHAR Global Consulting - All Rights Reserved.

  • Home

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept